| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20017283 | HPV | ENSG00000104921.15 | protein_coding | FCER2 | No | No | 2208 | K3W4U1 P06734 |
| TVIS44021337 | HTLV-1 | ENSG00000104921.15 | protein_coding | FCER2 | No | No | 2208 | K3W4U1 P06734 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | FCER2 |
|---|---|
| DrugBank ID | DB06162 |
| Drug Name | Lumiliximab |
| Target ID | BE0003465 |
| UniProt ID | P06734 |
| Regulation Type | antibody |
| PubMed IDs | 18032710; 21317446 |
| Citations | Pathan NI, Chu P, Hariharan K, Cheney C, Molina A, Byrd J: Mediation of apoptosis by and antitumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines. Blood. 2008 Feb 1;111(3):1594-602. Epub 2007 Nov 21.@@Schnaiter A, Stilgenbauer S: Refractory chronic lymphocytic leukemia--new therapeutic strategies. Oncotarget. 2010 Nov;1(7):472-82. doi: 10.18632/oncotarget.101103. |
| Groups | Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | |
| ChEMBL |
